India’s Growth Sectors - Pharmaceuticals & Biotech medical presentation

Pharmaceuticals and Biotech Medical Notes

About This Presentation

Description:India has the 2nd highest number of qualified doctors if we talk about the world. Interestingly, of every six medical doctors in the US, one is Indian

Tags:Pharmaceuticals , Biotech

Published on: Jan 10, 2017 | Views : 4698 | Downloads : 0

Comment

Transcript

Slide 1-

India’s Growth Sectors - Pharmaceuticals and Biotech Khushbu Shrivastava Gupta Editor @MedicPresents Master of Technology (M.Tech.), Biotechnology
Slide 2-

To be sure… The Indian Pharmaceutical Industry has practically achieved Self-sufficiency and Global recognition as a Low cost producer of High-quality bulk drugs and formulations.
Slide 3-

Growth in Pharmaceuticals & Biotech - KEY ACHIEVEMENTS India has the 2nd highest number of qualified doctors if we talk about the world. Interestingly, of every six medical doctors in the US, one is Indian India’s huge population and the prevalence of a wide spectrum of disease conditions offer a wide patient-resource for clinical trials While clinical trials cost approximately $300 to 350 million in US, they cost only about $25 million in India Investigational New Drug stage costs about $100 to 150 million in US, but costs only around $10 to 15 million in India 700,000 science and engineering graduates & 1500 PhDs qualify annually. Over 15,000 scientists
Slide 4-

Indian companies are offering custom synthesis services at 30-50% cost savings compared to global costs CHANGING FACE OF INDIAN PHARMACUTICAL INDUSTRY Indian pharma companies filed the largest number of Drug Master Files (DMFs) for APIs and 23% of ANDAs with the USFDA during 2003 Export revenues now contribute over half the total revenues for the Indian pharma majors Ranbaxy acquired RPG Aventis, France; Wockhardt acquired CP Pharmaceuticals, UK; Zydus Cadila acquired Alpharma, France Pharmaceutical exports increased at a CAGR of 23% during FY1995-FY2002 CHANGING FACE OF INDIAN PHARMA MNC-Domestic Competition Co-marketing - Glaxo-Cipla, Wockhardt-Bayer, Ranbaxy-Knoll tie-ups New Drug Research - Glaxo SmithKline's recent R&D alliance with Ranbaxy Laboratories Pharma – IT - Novartis processes drug safety data and is designing clinical development software Clinical Trials - Novartis, Astra Zeneca and Eli Lilly making India a global hub for clinical trials In-licensing - Ranbaxy licensing agreement with KSB, UK for marketing TransMID Local research - Astra Zeneca’s $40 million R&D facility in Bangalore for TB drug discovery
Slide 5-

BIOTECHNOLOGY Market - A Consistent Uptrend 2002-03 25% growth in investment 70% growth in employment 74% growth in R&D manpower 2010 USD 5 billion annual revenues 1 million skilled jobs 10% of global industry
Slide 6-

GOING GLOBAL IN BIOTECH Shantha Biotech- SHANVAC-B meets 40% of the global demand of Hepatitis B vaccine. Clinton Foundation sourcing HIV treatment from four firms - three of which are from India Biocon was the first enzyme company globally to receive ISO certification in 1993 Bio Agri - India (2nd largest producer of food) offers significant opportunities to source products Biogenerics - $25 billion biological products going off patent in 2004. Indian companies strong in biogenerics
Slide 7-

India’s first genetically engineered vaccine costs less than half the price of competing vaccines
Slide 8-

India: largest producer of Measles & DTP vaccines. Vaccine exports to over 130 countries
Slide 9-

The India Advantage Excellent network of research laboratories Well-developed base industries Rich biodiversity
Slide 10-

Extensive clinical trials opportunities Trained manpower and knowledge base

User Presentation
Related Presentations

Online Marketing Strategies for Your Practice

By: anupma
Views: 2337

HIV and AIDS - The Myths and Facts

By: anupma
Views: 5173

Pharmaceuticals and Biotech

By: anupma
Views: 4698

Global pharma and Indian pharmaceutical industry: Prospects for growth

By: anupma
Views: 1542

How did the Indian Pharmaceutical Market Become Self-Sufficient

By: anupma
Views: 1460

Rethinking Model Scaling for Convolutional Neural Networks

By: pouya
Views: 1462

Reopening the United States Health System - Tracking the Pandemic, Reopening Readiness

By: docshare
Views: 1498

Check it out

By: fakoladeolayemi
Views: 1436

FHL2 interacts with EGFR

By: ashnasagar8
Views: 1569

Deloitte's 2019 Global health care outlook

By: MattB
Views: 2730

anupma

About : A Healthcare MarCom professional...I have experience on managing healthcare marketing communication online...on website, social media and off course email.
Occupation : Health Enthusiast
Specialty : Health Enthusiast
Country : India
Website : https://www.medicpresents.com

HEALTH A TO Z